Ascites and spontaneous bacterial peritonitis: abdominal fluid, infection and urgent care

Ascites is abnormal fluid accumulation in the abdominal cavity. Spontaneous bacterial peritonitis (SBP) is bacterial infection of that fluid without an abdominal source requiring surgical treatment. They are different problems: a swollen abdomen does not establish infection, and serious illness needs assessment rather than a home fluid or antibiotic plan. Confidence is high in this distinction; the cause of ascites and any suspected infection require clinical investigation.

Evidence summary

Clinical guidance, human outcome research and funding independence answer different questions. The guidance below explains care; it does not independently reproduce the trials behind a medicine or supplement.

What ascites and SBP mean

Cleveland Clinic describes abdominal enlargement, discomfort, leg swelling, reduced mobility and breathlessness with ascites. Selected January2025 symptom context. A visibly enlarged abdomen can have other explanations; an appearance or weight change does not confirm the diagnosis.

BSG/BASL distinguishes SBP from infection arising from an inflamed or perforated organ. Selected distinction. Ask which problem the team suspects. “Peritonitis” is a broader term, and these labels should not be used interchangeably in a care plan.

This guide explains the adult cirrhosis-related framework and selected patient education. It does not transfer that framework to every cause of abdominal fluid or to children. A clinician should explain whether liver disease is established, suspected or one of several possibilities.

Why abdominal fluid accumulates

Cirrhosis can involve portal hypertension and retention of salt and water. Other causes include heart failure, kidney disease, cancer and tuberculosis. Selected mechanism and alternative causes. Do not assume that all ascites is caused by alcohol or that treating a liver condition addresses every case.

CUH separates treatment of cirrhosis’s underlying cause from management of complications. Selected wider-care context. Ask which part of the plan addresses the cause, which addresses fluid and which is intended to prevent or treat infection.

Tell the team about known liver, cardiac or kidney disease and previous abdominal-fluid investigations. Bring earlier imaging and discharge information when available. These details can help explain the clinical question without making a single past diagnosis the answer to every new change.

Diagnostic paracentesis and interpretation of results

BSG/BASL recommends fluid testing for new ascites and prompt SBP assessment with admission or deterioration in cirrhosis. Selected diagnostic framework. Ask how the cell count and culture inform the assessment; no home laboratory threshold is supplied.

Cleveland Clinic describes examination, blood tests and selected imaging to assess fluid and possible causes. Selected investigation context. Ask what each investigation is intended to resolve; a list of possible tests is not a universal testing order.

Clarify whether a proposed tap is for diagnosis, symptom relief or both. Ask who will review the results, which are still pending and what action follows if the original explanation is uncertain. The amount drained and the infection assessment answer different questions. A reassuring-looking sample is not a substitute for its clinical interpretation.

Nutrition, salt, fluid and supplement claims

CUH’s liver-diet information emphasizes adequate protein and avoiding muscle loss. Selected nutrition principle. Request a dietitian’s plan that fits appetite, food intake and other illnesses; a restrictive liver diet should not make adequate eating impossible.

National NHS cirrhosis education includes dietary advice and prescribed treatment for fluid-related problems. Selected care context. Ask for the actual salt and drinking instructions for the diagnosis and current blood results. No universal sodium target, fluid volume or body-weight cutoff is provided here.

NCCIH warns that supplements can interact with medicines and some can injure the liver. Selected safety warning. Show the team teas, extracts and powders as well as tablets. No “detox,” antimicrobial supplement or seller-promoted fluid remedy is established here as an independently cleared treatment for ascites or SBP.

Antibiotics, drainage and treatment goals

BSG/BASL calls for immediate antibiotics selected for severity, infection setting and local resistance. Attributed infection-care context. This is clinical guidance; the article has not independently cleared every underlying antibiotic trial or ranked drugs.

CUH describes therapeutic paracentesis using a drain under local anaesthetic, with assessment and monitoring. Selected procedure context. Ask how drainage fits the wider plan. Removing accumulated fluid and treating its cause are separate goals; no universal drain interval or home technique is supplied.

The provider describes selected albumin use during drainage. Selected supportive-care context. Ask why it is proposed in the actual situation, rather than interpreting a leaflet as an instruction for every person or every volume removed.

A TIPSS creates an alternative route for portal blood flow. CUH describes selected use for ascites that persists despite other care. Selected shunt role. Ask about suitability, alternatives and follow-up. A procedure’s place in clinical care does not establish an independently screened comparative outcome here.

Urgent symptoms and treatment harms

Cleveland Clinic advises emergency assessment for fever or intense abdominal pain with ascites. Selected urgent warnings. Seek local emergency care; do not wait for a routine drainage appointment or treat suspected infection with leftover antibiotics.

The national NHS treats sudden confusion or slurred speech in cirrhosis, vomiting blood and black stools as emergency warning signs. Do not drive yourself for emergency care. Current emergency advice. Tell responders about known liver disease, ascites and recent procedures.

CUH lists bleeding, organ injury, infection, low blood pressure and kidney effects as potential drainage risks. Selected consent information. Ask how your risks will be assessed and what symptoms need contact afterward. This guide does not promise that a procedure is painless, risk-free or suitable for immediate independent travel.

BSG/BASL requires monitoring for diuretic adverse effects. Selected medicine-safety context. Request a review plan and a contact if treatment is difficult to tolerate; no self-directed dose change is provided.

Medicine review and interaction questions

Tell the prescriber and pharmacist about all medicines, allergies and nonprescription products. Ask which are intended to manage fluid, infection, blood pressure, pain or another condition. Similar-looking prescriptions can have different purposes, and instructions from different services should be reconciled.

If an antibiotic is prescribed, ask whether it treats the current episode or prevents another episode, how the choice fits the clinical results and who will review it. Do not infer an indefinite course merely from having abdominal fluid or from remembering an earlier infection prescription.

A water-tablet or blood-pressure plan may need review when the person becomes acutely ill. Explain any poor intake, vomiting, diarrhoea or new difficulty following treatment to the team. This guide does not give a medicine stop rule or an instruction to increase drinking when someone also has cardiac, kidney or fluid-balance problems.

Who needs individualized assessment

Treatment for cirrhosis-associated ascites should not be copied into cancer-related, cardiac or kidney-related ascites. Ask whether more than one cause is contributing and which service is coordinating care. A shared-care plan should explain who reviews medicine and procedure decisions.

CUH identifies confusion as a possible complication of a TIPSS. Selected safety context. Tell the team about previous mental-state changes before considering a shunt. No age cutoff, score, automatic eligibility decision or procedure risk rate is offered here.

Pregnancy, childhood, infection, major heart or kidney disease, difficulty eating and limited support at home deserve a specific discussion. Explain the practical concerns before discharge, including how appointments, medicines and transport will be managed. These are questions for the treating service, not reasons to self-select a different regimen.

Recurrence prevention and a written care plan

BSG/BASL describes selected antibiotic prevention and acknowledges uncertainties in primary prophylaxis. Selected prevention context. Ask whether prevention is indicated, what benefit is expected and what harms or review needs matter; this is not a recommendation that everyone with ascites take an antibiotic.

Request a written account of the established cause, recent fluid results, medicine purposes, procedure plan and urgent warning signs. Ask who to contact when symptoms change and who communicates pending cultures or other results. Keep the plan accessible to carers and the services involved.

Ask the clinician how to follow changes in symptoms or weight and what should prompt contact in your situation. Do not copy another person’s drainage schedule, dietary numbers or laboratory thresholds. If repeated procedures are difficult, ask about alternatives and the goals of continuing care; those questions deserve a clinical discussion rather than a product recommendation.

Experimental devices and laboratory research

Research may investigate fluid-control devices, infection detection or liver and kidney pathways. A technically successful drain, biomarker change or laboratory result does not by itself establish better symptoms, fewer admissions or longer survival. Those outcomes and the harms need appropriate human comparisons.

No animal or in-vitro result or manufacturer-backed device outcome is adopted as independent efficacy evidence here. If a device or investigational treatment is proposed, ask about the actual evidence, sponsor and investigator interests, alternatives and consent. A professional guideline mentioning a technology does not clear the finances of the original device studies.

Funding and source roles

The dated framework is used for attributed clinical context, with author interests visible. The separate BSG status page records a December2024 validity review, not a new clinical trial. No independent drug, albumin or device benefit estimate is claimed.

Provider financial accounts and national website funding were checked separately. Public commissioning, nonprofit status and medical checking do not establish complete author independence. Exact leaflet payments, full partner chains and original-study finance remain unclosed; sponsored efficacy is excluded from the independent verdict.

Frequently asked questions

Does abdominal swelling prove SBP? No. Ask what has established fluid and what testing is needed to investigate infection; do not make the diagnosis from appearance.

Is a tap always only for drainage? Ask whether the purpose is testing, symptom relief or both, and how results will be communicated.

Should I wait for my next tap if I develop fever and severe pain? Seek emergency assessment. Urgent warning context.

Does a previous SBP episode mean lifelong antibiotics for everyone? Ask the treating team to explain the prevention indication and review plan; no blanket duration is supplied.

Can I manage the fluid by restricting protein or drinking less? Obtain a dietitian and clinician’s written plan rather than imposing a new restriction yourself.

Is drainage a cure for the cause? Ask which part of your treatment addresses the underlying diagnosis and how that response will be assessed.

Sources and funding notes

The full BSG/BASL original and declarations were read; clinical context and the separate validity review do not clear underlying trials. Selected provider and national originals were read at the dates shown. Personal weight/sodium targets, blanket long-term antibiotics, absolute TIPSS benefits and all-ascites liver-damage claims are excluded. The drainage account does not supply universal clot correction/transfusion, a fixed interval, a home procedure or automatic travel clearance. Full RCR/BSIR adaptation finance remains unclosed. Current provider accounts, national finance and dated NCCIH financial originals were checked separately; complete BASL, contributor and original-study chains remain unclosed.

1. Original BSG/BASL ascites guideline, October2020, full21p — Selected dated diagnostic/infection/prevention and medicine-monitoring framework; no personal thresholds or outcome estimate
2. BSG ascites guideline review, December2024; next2027 — Actual December2024 validity review only; not new2024 clinical evidence
3. Cleveland Clinic ascites, January30,2025; selected context — Selected January2025 definition/symptoms/causes/testing/urgent context; broad prognostic and protocol claims excluded
4. Cambridge University Hospitals paracentesis, March31,2025 — Selected March2025 therapeutic-drain/consent/monitoring context; universal blood-product, timing and travel claims excluded
5. Cambridge University Hospitals TIPSS education, January14,2025 — Selected January2025 shunt role and confusion risk; no selection thresholds or efficacy estimate
6. Cambridge University Hospitals protein/liver-disease education, May28,2025 — Selected May2025 adequate nutrition principle; no brands or targets
7. Cambridge University Hospitals cirrhosis education, June20,2024 — Selected June2024 cause/complication distinction
8. National NHS cirrhosis, February10,2025; selected emergency context — Selected February2025 emergency/care context
9. NCCIH supplement safety, January2019; selected safety context only — Dated supplement safety only
10. BSG own industry-partnership route and London contact — Separate actual society partnership/contact route; full ledger unclosed
11. Cleveland Clinic own2025/2024 audited accounts, March9,2026 — Separate actual current audited provider financial routes
12. Cleveland Clinic own advertising policy, January2020 — Separate dated advertising policy
13. Cleveland Clinic own medical editorial policy — Separate own editorial-governance statement
14. Cambridge University Hospitals own2025–2026 audited accounts — Separate actual current provider accounts
15. NHS England own 2025–2026 audited accounts — Separate current national institutional finance
16. National NHS website content and funding policy, 2022 — Separate national website policy, not hospital finances
17. NCCIH actual appropriation history, through FY2024 — Historical appropriation route only
18. NCCIH separate conditional/unconditional Gift Fund authority — Separate permitted Gift Fund authority

Educational information reviewed 4 October 2026. This guide supports an informed clinical discussion; it does not diagnose an individual or provide a personal treatment regimen.